Our project will hopefully provide proof of principle that gene therapy could one day provide lasting control of normal eye pressure in patients with known genetic defects. (glaucoma.org)
The most significant risk factor for the development and advancement of this form is high eye pressure. (brightfocus.org)
Higher doses were protective 93 percent of the time and it also lowered eye pressure in many of the animals. (mdibl.org)